Publications 2024

Galtung KF, Lauritzen PM, Rud E (2024)
Reply to Fabio Zattoni, Fabrizio Dal Moro, Iliana Bednarova, and Giacomo Novara's Letter to the Editor re: Kristina F. Galtung, Peter M. Lauritzen, Gunnar Sandbæk, et al. Is a Single Nephrographic Phase Computed Tomography Sufficient for Detecting Urothelial Carcinoma in Patients with Visible Haematuria? A Prospective Paired Noninferiority Comparison. Eur Urol Open Sci 2023;55:1-10
Eur Urol Open Sci, 61, 54-55
DOI 10.1016/j.euros.2024.01.014, PubMed 38357532

Galtung KF, Lauritzen PM, Sandbæk G, Bay D, Ponzi E, Baco E, Cowan NC, Naas AM, Rud E (2024)
Computed tomography for visible haematuria - a single nephrographic phase is sufficient for detecting renal cell carcinoma
Scand J Urol, 59, 10-18
DOI 10.2340/sju.v59.18467, PubMed 38226799

Publications 2023

Galtung KF, Lauritzen PM, Sandbæk G, Bay D, Ponzi E, Baco E, Cowan NC, Naas AM, Rud E (2023)
Is a Single Nephrographic Phase Computed Tomography Sufficient for Detecting Urothelial Carcinoma in Patients with Visible Haematuria? A Prospective Paired Noninferiority Comparison
Eur Urol Open Sci, 55, 1-10
DOI 10.1016/j.euros.2023.06.005, PubMed 37693732

Lauritzen PM, Jacewitz M, Baco E, Rud E, NORAPP authors (2023)
Re: Peter Ka-Fung Chiu, Veeru Kasivisvanathan, Giorgio Gandaglia, European Association of Urology Young Academic Urologists Prostate Cancer Working Party. Moving the Needle: Antibiotic Prophylaxis Is No Longer Required in the Era of Transperineal Prostate Biopsy. Eur Urol. 2023;84:154-55
Eur Urol, 85 (4), e118-e119
DOI 10.1016/j.eururo.2023.06.024, PubMed 37482513

Publications 2022

Galtung KF, Lauritzen PM, Baco E, Berg RE, Naas AM, Rud E (2022)
Predictive Performance of Prospectively Applied ISUP and Fuhrman Grade in Nonmetastatic Renal Cell Carcinoma
Anticancer Res, 42 (6), 2967-2975
DOI 10.21873/anticanres.15780, PubMed 35641263

Jacewicz M, Günzel K, Rud E, Sandbæk G, Magheli A, Busch J, Hinz S, Baco E (2022)
Antibiotic prophylaxis versus no antibiotic prophylaxis in transperineal prostate biopsies (NORAPP): a randomised, open-label, non-inferiority trial
Lancet Infect Dis, 22 (10), 1465-1471
DOI 10.1016/S1473-3099(22)00373-5, PubMed 35839791

Rud E, Lauritzen P, Jacewicz M, Baco E, authors of the NORAPP study (2022)
Antibiotic prophylaxis for transperineal prostate biopsy? An unanswered question - Authors' reply
Lancet Infect Dis, 22 (12), 1663
DOI 10.1016/S1473-3099(22)00736-8, PubMed 36356607

Rud E, Noor D, Galtung KF, Ottosson F, Jacewicz M, Baco E, Lauritzen PM (2022)
Validating the screening criteria for bone metastases in treatment-naïve unfavorable intermediate and high-risk prostate cancer - the prevalence and location of bone- and lymph node metastases
Eur Radiol, 32 (12), 8266-8275
DOI 10.1007/s00330-022-08945-7, PubMed 35939081

Publications 2021

Jacewicz M, Rud E, Galtung KF, Noor D, Baco E (2021)
Cancer Detection Rates in Targeted Transperineal MRI-TRUS Elastic Fusion-guided Prostate Biopsies Performed Under Local Anesthesia
Anticancer Res, 41 (9), 4395-4400
DOI 10.21873/anticanres.15244, PubMed 34475059

Publications 2020

Jacewicz M, Günzel K, Rud E, Lauritzen PM, Galtung KF, Hinz S, Magheli A, Baco E (2020)
Multicenter transperineal MRI-TRUS fusion guided outpatient clinic prostate biopsies under local anesthesia
Urol Oncol, 39 (7), 432.e1-432.e7
DOI 10.1016/j.urolonc.2020.11.009, PubMed 33257219

Ottosson F, Baco E, Lauritzen PM, Rud E (2020)
The prevalence and locations of bone metastases using whole-body MRI in treatment-naïve intermediate- and high-risk prostate cancer
Eur Radiol, 31 (5), 2747-2753
DOI 10.1007/s00330-020-07363-x, PubMed 33141299

Publications 2019

Normann MC, Türzer M, Diep LM, Oldenburg J, Gajdzik B, Solheim O, Rud E (2019)
Early experiences with PD-1 inhibitor treatment of platinum resistant epithelial ovarian cancer
J Gynecol Oncol, 30 (4), e56
DOI 10.3802/jgo.2019.30.e56, PubMed 31074244

Rud E, Galtung KF, Lauritzen PM, Baco E, Flatabø T, Sandbæk G (2019)
Examining the upper urinary tract in patients with hematuria-time to revise the CT urography protocol?
Eur Radiol, 30 (3), 1664-1670
DOI 10.1007/s00330-019-06521-0, PubMed 31748856

Rud E, Langberg CW, Baco E, Lauritzen P, Sandbæk G (2019)
MRI in the Follow-up of Testicular Cancer: Less is More
Anticancer Res, 39 (6), 2963-2968
DOI 10.21873/anticanres.13427, PubMed 31177136

Publications 2018

Rud E, Diep L, Baco E (2018)
A prospective study evaluating indirect MRI-signs for the prediction of extraprostatic disease in patients with prostate cancer: tumor volume, tumor contact length and tumor apparent diffusion coefficient
World J Urol, 36 (4), 629-637
DOI 10.1007/s00345-018-2171-4, PubMed 29349572

Rud E, Lauritzen P, Baco E (2018)
Re: Henrik Grönberg, Martin Eklund, Wolfgang Picker, et al. Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging. Eur Urol 2018;74:722-8
Eur Urol, 75 (4), e103
DOI 10.1016/j.eururo.2018.11.047, PubMed 30528223

Publications 2016

Baco E, Rud E, Vlatkovic L (2016)
Reply to Yi Zhou, Weigang Yan, and Hanzhong Li's Letter to the Editor re: Eduard Baco, Erik Rud, Lars Magne Eri, et al. A Randomized Controlled Trial to Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy. Eur Urol 2016;69:149-56
Eur Urol, 70 (2), e55
DOI 10.1016/j.eururo.2016.01.031, PubMed 26852076

Rud E, Baco E (2016)
Re: Jeffrey C. Weinreb, Jelle O. Barentsz, Peter L. Choyke, et al. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol 2016;69:16-40: Is Contrast-enhanced Magnetic Resonance Imaging Really Necessary When Searching for Prostate Cancer?
Eur Urol, 70 (5), e136
DOI 10.1016/j.eururo.2016.04.017, PubMed 27126376

Publications 2015

Baco E, Rud E, Eri LM, Moen G, Vlatkovic L, Svindland A, Eggesbø HB, Ukimura O (2015)
A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy
Eur Urol, 69 (1), 149-56
DOI 10.1016/j.eururo.2015.03.041, PubMed 25862143

Rud E, Baco E, Klotz D, Rennesund K, Svindland A, Berge V, Lundeby E, Wessel N, Hoff JR, Berg RE, Diep L, Eggesbø HB, Eri LM (2015)
Does preoperative magnetic resonance imaging reduce the rate of positive surgical margins at radical prostatectomy in a randomised clinical trial?
Eur Urol, 68 (3), 487-96
DOI 10.1016/j.eururo.2015.02.039, PubMed 25813692

Rud E, Sandbæk G (2015)
[Guidelines in the wrong direction]
Tidsskr Nor Laegeforen, 135 (22), 2036
DOI 10.4045/tidsskr.15.1009, PubMed 26627289

Publications 2014

Baco E, Gelet A, Crouzet S, Rud E, Rouvière O, Tonoli-Catez H, Berge V, Chapelon JY, Eggesbø HB (2014)
Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study
BJU Int, 114 (4), 532-40
DOI 10.1111/bju.12545, PubMed 24930692

Baco E, Rud E, Ukimura O, Vlatkovic L, Svindland A, Matsugasumi T, Bernhard JC, Rewcastle JC, Eggesbø HB (2014)
Effect of targeted biopsy guided by elastic image fusion of MRI with 3D-TRUS on diagnosis of anterior prostate cancer
Urol Oncol, 32 (8), 1300-7
DOI 10.1016/j.urolonc.2014.07.014, PubMed 25189687

Baco E, Rud E, Vlatkovic L, Svindland A, Eggesbø HB, Hung AJ, Matsugasumi T, Bernhard JC, Gill IS, Ukimura O (2014)
Predictive value of magnetic resonance imaging determined tumor contact length for extracapsular extension of prostate cancer
J Urol, 193 (2), 466-72
DOI 10.1016/j.juro.2014.08.084, PubMed 25150643

Baco E, Ukimura O, Rud E, Vlatkovic L, Svindland A, Aron M, Palmer S, Matsugasumi T, Marien A, Bernhard JC, Rewcastle JC, Eggesbø HB, Gill IS (2014)
Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients
Eur Urol, 67 (4), 787-94
DOI 10.1016/j.eururo.2014.08.077, PubMed 25240973

Rud E, Baco E, Lien D, Klotz D, Eggesbø HB (2014)
Detection of radiorecurrent prostate cancer using diffusion-weighted imaging and targeted biopsies
AJR Am J Roentgenol, 202 (3), W241-6
DOI 10.2214/AJR.12.10483, PubMed 24555620

Rud E, Klotz D, Rennesund K, Baco E, Berge V, Lien D, Svindland A, Lundeby E, Berg RE, Eri LM, Eggesbø HB (2014)
Detection of the index tumour and tumour volume in prostate cancer using T2-weighted and diffusion-weighted magnetic resonance imaging (MRI) alone
BJU Int, 114 (6b), E32-E42
DOI 10.1111/bju.12637, PubMed 24447606

Rud E, Klotz D, Rennesund K, Baco E, Johansen TE, Diep LM, Svindland A, Eri LM, Eggesbø HB (2014)
Preoperative magnetic resonance imaging for detecting uni- and bilateral extraprostatic disease in patients with prostate cancer
World J Urol, 33 (7), 1015-21
DOI 10.1007/s00345-014-1362-x, PubMed 25059766

Publications 2012

Rud E, Baco E, Eggesbø HB (2012)
MRI and ultrasound-guided prostate biopsy using soft image fusion
Anticancer Res, 32 (8), 3383-9
PubMed 22843919